Latest news
Morgan Stanley Hikes Metropolis Healthcare's Target Price On Healthy Volume Growth; But Prefers Dr. Lal Pathlabs - NDTV ProfitNDTV Profit · Thu, 06 Aug 2026 03:36:24 GMTLALPATHLAB Outlook for the Week (August 10, 2026 – August 14, 2026) - equitypandit.comequitypandit.com · Fri, 31 Jul 2026 07:00:00 GMTDr. Lal PathLabs Q1FY27 profit surges 27% on volume growth - scanx.tradescanx.trade · Thu, 30 Jul 2026 07:00:00 GMTDr. Lal PathLabs Limited Just Missed Earnings - But Analysts Have Updated Their Models - simplywall.stsimplywall.st · Tue, 28 Jul 2026 07:00:00 GMTDr Lal PathLabs Number of Employees 2026 | Employee Count & Headcount Data - Revelio LabsRevelio Labs · Tue, 28 Jul 2026 06:30:10 GMTHold Dr Lal Pathlabs; target of Rs 1690: ICICI Securities - TradingViewTradingView · Mon, 27 Jul 2026 07:37:10 GMTDr. Lal PathLabs spurts after Q1 PAT rises 27% YoY; extends rally to second day - Business StandardBusiness Standard · Mon, 27 Jul 2026 07:20:41 GMTDr Lal PathLabs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are - The Economic TimesThe Economic Times · Mon, 27 Jul 2026 07:00:00 GMT